Views Navigation

Event Views Navigation

Today

What has Brain Imaging Taught us about Addiction?

Edythe London, PhD will be joining us to discuss how the imaging of brain structure, chemistry and function is possible using noninvasive techniques that have been applied to the study […]

The Neurobiology of Addiction

Presenter: Steven Straubing, MD Cost: No fee Target Audience: This activity was developed to meet the needs of physicians and all interprofessional healthcare providers. This discussion is designed to promote […]

Tobacco Regulations Across the Continuum of Harm

Tracy Smith, PhD Assistant Professor of Psychiatry and Behavioral Services Medical University of South Carolina   The VCBH Monthly Lecture Series was originally created as an in-person series designed as […]

Alcohol Use Disorder (FAME Session #3)

Presenters: Abby Letcher, MD, FASAM; Angela Colistra, PhD, LPC, CAADC, CCS; Shanna Diaz, DO Series: This 2-hour, virtual-live session is part of the FAME 8-session series and will cover overdose prevention […]

The Connection Between Mental Health and Opioid Use Disorder

Presenter: Mark Duncan, MD, Assistant Professor, University of Washington, Director, UW Psychiatry and Addictions Case Conference Sponsor: American Psychiatric Association (APA) Cost: No Fee Target audience: Physicians, nurse practitioners or other advanced […]

Illicit Drug Supply: Fentanyl and Xylazine

Presenter: Richard Dawson, PhD, Research Professor at the Vermont Center for Behavior and Health at UVM and a Professor Emeritus at the UCLA Department of Psychiatry This presentation will explore current […]

Substance Use Disorders in Late Life

Register Now   Presenters: Roberto D. Sanchez, DO and Ali Abbas Asghar-Ali, MD Target Audience: This activity is designed for Psychiatrists, Physicians, Physician Assistants, Nurses/Nurse Practitioners, Social Workers, Psychologists, Pharmacists, […]

Nurses’ Practices with People Experiencing Opioid Use Disorder

Register Now   Presenter: Timothy J. Sowicz, PhD, RN Cost: No Fee Target audience: This activity is designed for for Nurses, MAT Team Providers, Addictions Specialists, SUD Project Directors, Managers, and Facilitators. This […]

Treatment Considerations in the Age of Fentanyl

Fentanyl and other high-potency synthetic opioids are increasingly present in the U.S. drug supply. Healthcare systems, treatment providers, and justice systems are grappling with the physiological consequences of chronic fentanyl […]

Initiating Buprenorphine for Patients Using Fentanyl

Register Now Presenter: Brian Hurley, MD, MBA, DFASAM, FAPA Cost: No Fee Target audience: Nurses, Addictions Specialists, SUD Project Directors, Managers, and Facilitators and MOUD (medications for opioid use disorder) providers Credit Designations […]

Xylazine and How it Harms People Who Use Drugs

Register now! Presenters: Raagini Jawa, MD Cost: No fee Target Audience: This activity was developed to meet the needs of physicians and all interprofessional healthcare providers. Description: We will review […]

Opioid Use Disorder and Social Determinants of Health

Presenters:   Rachel Talley, MD, Assistant Professor of Clinical Psychiatry/Director, Fellowship in Public and Community Psychiatry Jessica Isom, MD, Attending Psychiatrist, Codman Square Health Center/Clinical Instructor, Yale University/Faculty Lead, Social Justice and Health Equity Curriculum Sponsor: National Council for Mental Wellbeing--NCMW Continuing education information: Council for Mental Wellbeing will not be providing Continuing Medical Education […]

Changing the Default: Moving to an Opt-Out Approach for Treating Tobacco Use Disorders

Join us on Wednesday, May 17th for the #VCBHLectureSeries as we welcome Kimber Richter, PhD, MPH, Professor of Population Health at the University of Kansas Medical Center. Dr. Richter will present "Changing the Default: Moving to an Opt-Out Approach for Treating Tobacco Use Disorders." Dr. Richter received her Master of Public Health from the University […]

Drug Use in Pregnancy (ASAM FAME Session 7)

Register Now Questions about registering should be directed to: ASAM Education by email ateducation@asam.org Presenters: Abby Letcher, MD, FASAM Angela Colistra, PhD, LPC, CAADC, CCS Shanna Diaz, DO Leslie Hayes, MD Series: This 2-hour, virtual-live session is part of the FAME 8-session series and will cover overdose prevention and harm reduction. The FAME series is a facilitated, […]

Nurse Practitioners and Physician Assistants as Buprenorphine Providers: Facilitators and Barriers

This presentation will describe the expansion of nurse practitioners and other advanced practice clinicians into opioid use disorder treatment, particularly in rural communities. It will also explore barriers and facilitators regarding nurse practitioner engagement in buprenorphine treatment, including regulations, education, and broader social factors such as stigma. Specific considerations for advanced practice clinicians' work with […]

Opioid Use Disorder in Pregnant and Postpartum People: The Treatment and Policy Landscape

Register Now Presenters: Maria Manriquez, MD, FACOG, FASAM, PMH-C; Tara Sundem, APRN, NNP-BC; and Tawni Carson Sponsor: National Council for Mental Wellbeing--NCMW NOTE: The National Council for Mental Wellbeing will not be providing Continuing Medical Education for this event. Target Audience: This activity is designed for interprofessional teams, families and patients, students and educators, nurses, […]

Expanding Harm Reduction Access in the US for Rural and Other Underserved Populations

This presentation will describe research around syringe service programs and methods of harm reduction distribution. Specific considerations for reaching members of rural communities will be discussed. Learning objectives: 1. Discuss the need for novel approaches for distributing harm reduction supplies 2. Describe benefits and challenges regarding syringe service programs 3. Outline specifics of programs that […]

A Qualitative Analysis of US State Laws Regulating Incentives for Health Behavior

This presentation will describe the results of a qualitative study examining state laws regulating incentives for health behavior. Such laws may have important implications for provision of contingency management for substance use disorder, including in rural areas. Register and attend to learn more! Speaker: Barbara "Basia" Andraka-Christou, PhD, JD, Assistant Professor in the School of […]

Providing Comprehensive Care in Opioid Treatment Program: A Policy and Provider Perspective

Presenters: Mark Parrino, President and CEO of The American Association for the Treatment of Opioid Dependence, Inc. Jennifer Seib, VP of Strategic Initiatives and Integration at BestSelf Behavioral Health Sponsor: National Council for Mental Wellbeing--NCMW Credit designational available: None Target Audience: Interprofessional teams, patients, educators, nurses, physicians, psychiatrists, psychologists, executives, clinical staff, administrators and social […]

Buprenorphine in the Age of Fentanyl: Discussing the New Guidance

Presenter: John Mariani, MD Target Audience: This activity was developed to meet the needs of physicians and interprofessional healthcare providers. Discussion is designed to promote interactivity through an informal "round table" conversation. Attendees will be given the opportunity to speak directly with the presenter to ask questions and discuss issues. Register now

Reaching People Where They’re At: Smoking Cessation Treatment Delivery at Your Door

This presentation will discuss novel ways to deliver evidence-based treatment for smoking cessation within and across rural areas. It will focus on 4 separate clinical trials of medication sampling, each demonstrating feasibility and efficacy of a simple yet novel treatment approach to reach a broad spectrum of smokers, including those who may not yet want […]